While the suburb is close enough to the action in the centre of Coventry, it’s far away enough that you can retreat into peaceful suburban solitude. The survey praised the eating options and the ...

Two villages outside Coventry have been named some of the best places to live in the West Midlands. Thanks to new survey data from Muddy Stilettos, Balsall Common and Hampton-in-Arden have made ...

The Coventry Police Department said a dog owner requested that their dog be killed because it had an aggressive temperament. It happened on Oct. 24. Investigators arrested Anthony Demitraszek as a ...

All doses of Novo Nordisk's weight loss injection Wegovy and diabetes drug Ozempic are now available in the U.S., according to an update on the FDA's drug shortage database. It is a sign that Novo ...

All impacted products have now been given a Class II recall classification by the U.S. Food and Drug Administration (FDA). A Class II recall is "a situation in which use of or exposure to a ...

Share on Pinterest A drug that has already gained FDA approval for the treatment of ulcerative colitis is also effective in the treatment of Crohn’s, new data suggest. Brothers91/Getty Images ...

Tonight will continue to see plenty of cloud around but some clear intervals are possible towards dawn. Mostly dry albeit isolated spots of light rain or drizzle may develop for a time. Monday ...

The FDA said Wednesday it has begun inspecting Taylor Farm’s processing center in Colorado Springs as well as an “onion grower of interest” in Washington state. It did not name the grower.

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli Lilly’s popular weight loss medication Zepbound and diabetes drug Mounjaro.

For the second time in less than a year, the FDA has issued a complete response letter to the company, citing the need for data on a third-party manufacturing site that had failed an earlier ...

In September, the FDA approved the drug previously known as KarXT as a novel antipsychotic therapy for adults with schizophrenia. Citing new topline data from its 52-week open-label studies ...

(Asian Journal of Psychiatry) In April, the FDA approved a new oral granule formulation of the vesicular monoamine transporter 2 (VMAT2) inhibitor valbenazine capsules (Ingrezza Sprinkle ...